Literature DB >> 12924676

Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder.

Richard A Bryant1, Michelle L Moulds, Rachel M Guthrie, Suzanne T Dang, Reginald D V Nixon.   

Abstract

This study investigated the extent to which providing cognitive restructuring (CR) with prolonged imaginal exposure (IE) would lead to greater symptom reduction than providing IE alone for participants with posttraumatic stress disorder (PTSD). Fifty-eight civilian survivors of trauma with PTSD were randomly allocated to IE/CR, IE, or supportive counseling (SC). Treatment involved 8 individual weekly sessions with considerable homework. Independent assessments were conducted pretreatment, posttreatment, and at 6-month follow-up. IE/CR and IE resulted in reduced PTSD and depression compared with SC at posttreatment and follow-up. Further, IE/CR participants had greater reductions in PTSD and maladaptive cognitive styles than IE participants at follow-up. These findings suggest that providing CR in combination with IE may enhance treatment gains.

Entities:  

Mesh:

Year:  2003        PMID: 12924676     DOI: 10.1037/0022-006x.71.4.706

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  60 in total

1.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

2.  Effects of exogenous glucocorticoid on combat-related PTSD symptoms.

Authors:  Alina Surís; Carol North; Bryon Adinoff; Craig M Powell; Robert Greene
Journal:  Ann Clin Psychiatry       Date:  2010-11       Impact factor: 1.567

3.  On the importance of distinguishing shame from guilt: relations to problematic alcohol and drug use.

Authors:  Ronda L Dearing; Jeffrey Stuewig; June Price Tangney
Journal:  Addict Behav       Date:  2005-04-13       Impact factor: 3.913

4.  Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder.

Authors:  Richard A Bryant; Kim Felmingham; Thomas J Whitford; Andrew Kemp; Gerard Hughes; Anthony Peduto; Leanne M Williams
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

5.  The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept.

Authors:  Maria L Pacella; Aaron Armelie; Jessica Boarts; Glenn Wagner; Tracy Jones; Norah Feeny; Douglas L Delahanty
Journal:  AIDS Behav       Date:  2012-07

6.  A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness.

Authors:  Kim T Mueser; Stanley D Rosenberg; Haiyi Xie; M Kay Jankowski; Elisa E Bolton; Weili Lu; Jessica L Hamblen; Harriet J Rosenberg; Gregory J McHugo; Rosemarie Wolfe
Journal:  J Consult Clin Psychol       Date:  2008-04

7.  Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

Authors:  Jenna L McCauley; Therese Killeen; Daniel F Gros; Kathleen T Brady; Sudie E Back
Journal:  Clin Psychol (New York)       Date:  2012-09-01

8.  Cognitive therapy for anxious depression in STAR(*) D: what have we learned?

Authors:  Amy Farabaugh; Jonathan Alpert; Stephen R Wisniewski; Michael W Otto; Maurizio Fava; Lee Baer; Roy Perlis; Ed Friedman; Maren Nyer; Stella Bitran; G K Balasubramani; Aya Inamori; Madhukar Trivedi; Michael E Thase
Journal:  J Affect Disord       Date:  2012-08-09       Impact factor: 4.839

9.  The applicability of randomized controlled trials of psychosocial treatments for PTSD to a veteran population.

Authors:  Shannon Wiltsey Stirman
Journal:  J Psychiatr Pract       Date:  2008-07       Impact factor: 1.325

10.  Enhancing clinical trial design of interventions for posttraumatic stress disorder.

Authors:  Andrew C Leon; Lori L Davis
Journal:  J Trauma Stress       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.